OncoAlert
At OncoAlert, we recognize the urgent need for accessible, high-quality oncology education and information. As one of the strongest oncology networks globally, we are committed to enhancing the quality of cancer care through tailored education, reflecting the varied needs of different regions. Since our founding, our flagship initiative has been ...
read more ↘
read more ↘
The 2024 OncoAlert Colloquium
OncoAlert
Year in Review: Gastric, Esophageal, & Liver Cancer Updates
FEATURING
Sharlene Gill
- 6 views
- April 17, 2025
OncoAlert
Year in Review: Metastatic Pancreatic Cancer
FEATURING
Benedikt Westphalen
- 4 views
- April 17, 2025
OncoAlert
Challenges in Breast Cancer Diagnosis and Treatment in Brazil
FEATURING
Jose Fernando Moura
- 13 views
- April 4, 2025
OncoAlert
Advanced HR+/HER2- Breast Cancer: Key 2024 Trial Highlights
FEATURING
Erika Hamilton
- 67 views
- April 3, 2025
OncoAlert
HER2+ mBC: Current Treatment Landscape and 2024 Key Trial Updates Including PATINA and DESTINY-Breast Trials
FEATURING
Stephanie Graff
- 65 views
- April 3, 2025
OncoAlert
2024 Treatment Landscape in Advanced TNBC: Key Trials and New Directions
FEATURING
Hope Rugo
- 44 views
- April 3, 2025
OncoAlert
HER2+ eBC in 2024: Neoadjuvant Therapies and Key Trial Highlights
FEATURING
Evandro de Azambuja
- 44 views
- April 3, 2025
OncoAlert
Fertility Preservation and Pregnancy After Breast Cancer
FEATURING
Matteo Lambertini
- 10 views
- April 3, 2025
OncoAlert
Surgical Oncology of the Breast: Advances During 2024
FEATURING
Jose Volders
- 8 views
- April 3, 2025
OncoAlert
Management of Breast Cancer Brain Metastasis
FEATURING
Fatima Cardoso
- 23 views
- April 3, 2025
OncoAlert
Advances in Breast Radiotherapy: 2024 Highlights
FEATURING
Icro Meattini
- 5 views
- April 3, 2025
OncoAlert
Personalizing TNBC Treatment Through Pathology & Diagnostics
FEATURING
Roberto Salgado
- 4 views
- April 3, 2025
OncoAlert
What’s New in AML: Treatment Advances and Key Trials in 2024
FEATURING
Fadi Haddad
- 27 views
- April 3, 2025
- 1
OncoAlert
Myeloma 2024 Key Trial Highlights: AQUILA, AURIGA, and REDIRECTT-1
FEATURING
Al-Ola Abdallah
- 43 views
- April 3, 2025
- 1
OncoAlert
Updates on Surgical Trials in Endometrial Cancer
FEATURING
Aleksandra Strojna
- 3 views
- April 1, 2025
OncoAlert
Updates on Surgical Trials in Ovarian Cancer
FEATURING
Alejandra Martinez
- 12 views
- April 1, 2025
OncoAlert
Evolving Medical Strategies in Vulvar & Vaginal Cancer
FEATURING
Cyrus Chargari
- 2 views
- April 1, 2025
OncoAlert
Managing GU Cancer With Limited Drug Availability
FEATURING
María Natalia Gandur Quiroga
- 3 views
- March 31, 2025
OncoAlert
Insights From Key 2024 Surgical Trials in Cervical Cancer
FEATURING
Nicolo Bizzarri
- 5 views
- March 31, 2025
OncoAlert
Medical Treatment of Advanced and Recurrent Endometrial Cancer: 2024 Year in Review
FEATURING
Annamaria Ferrero
- 28 views
- March 31, 2025
OncoAlert
Overview of 2024 Key Trials in GU Radiotherapy
FEATURING
Sean McBride
- 12 views
- March 31, 2025
OncoAlert
Overview of 2024 Practice-Changing Trials in Prostate and Bladder Cancer
FEATURING
María José Juan-Fita
- 37 views
- March 30, 2025
- 1
OncoAlert
Medical Treatment of Locally Advanced and Metastatic Cervical Cancer: 2024 Year in Review
FEATURING
Domenica Lorusso
- 46 views
- March 28, 2025
- 1
OncoAlert
2024 Updates in Clinical Practice for Ovarian Cancer
FEATURING
Isabelle Ray-Coquard
- 31 views
- March 28, 2025
- 1
OncoAlert
Surgical Treatment of Vaginal Cancer
FEATURING
Christina Fotopoulou
- 28 views
- March 28, 2025
- 1
OncoAlert
GU Podcast: 2024 Highlights From Practice-Changing Trials in Prostate, Bladder, and Kidney Cancer
FEATURING
Renu Eapen,
Declan Murphy
- 87 views
- March 28, 2025
- 2
OncoAlert
Overview of 2024 Practice-Changing Trials in Renal Cancer
FEATURING
Elena Sevillano
- 27 views
- March 28, 2025
- 1
OncoAlert
Kidney Cancer 2024 Year in Review: Updates in Key Clinical Trials, Treatment Advances, and Biomarkers
FEATURING
Wenxin Xu
- 55 views
- March 25, 2025
- 1
OncoAlert
Prostate Cancer 2024 Year in Review: Key Trial Insights Including PACE-B, PEACE-1, PEACE-3, and PSMAfore
FEATURING
Silke Gillessen
- 83 views
- March 25, 2025
- 1
OncoAlert
Bladder Cancer 2024 Year in Review: Key Trials Including NIAGARA, AMBASSADOR, CheckMate 901, EV-302, & TROPiCS-04
FEATURING
Petros Grivas
- 72 views
- March 25, 2025
- 1
OncoAlert
Most Important Melanoma Treatment Updates From 2024
FEATURING
Allison Betof Warner
- 77 views
- March 18, 2025
- 1
OncoAlert
An Update of ADC Toxicities in Solid Tumors
FEATURING
Maryam Lustberg
- 88 views
- March 18, 2025
- 1
OncoAlert
Early Stage NSCLC: Adjuvant & Neoadjuvant Chemo + IO, Adjuvant Alectinib, Osimertinib After CRT in Stage 3 Disease
FEATURING
Gilberto Lopes
- 28 views
- March 13, 2025
- 2
OncoAlert
Updates in NSCLC: Top Trial Highlights From 2024 (LAURA, CROWN, REACH PC, and MARIPOSA-2)
FEATURING
Charu Aggarwal
- 25 views
- March 13, 2025
- 1
OncoAlert
SCLC & Mesothelioma Recent Treatment Updates
FEATURING
Jarushka Naidoo
- 36 views
- March 13, 2025
- 1
OncoAlert
NSCLC & SCLC Key Radiotherapy Updates From 2024
FEATURING
Henning Willers,
Katie Keane
- 25 views
- March 13, 2025
- 1
OncoAlert
Lung Cancer Pathology: Predictive Markers and Diagnostics Updates From 2024
FEATURING
Umberto Malapelle
- 61 views
- March 13, 2025
- 2
OncoAlert
The Microbiome's Role in Mucositis: Pathogenesis, Evidence, and Patient Care
FEATURING
Hannah Rose Wardill
- 4 views
- March 13, 2025
- 1
OncoAlert
Microbiota & Oral Mucositis: Treatment, Prevention, and Future Therapies
FEATURING
Paolo Bossi
- 9 views
- March 13, 2025
- 1